Norwegian Pharmaceuticals & Biotech Top Stock Picks from Analysts

Results

0 new

Companies which are more than 50% undervalued based on analyst price target.

2 companies

Nykode Therapeutics

Market Cap: NOK 1.1b

A clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies for the treatment of cancer and autoimmune diseases.

NYKD

NOK 3.24

-1.7%

80.9%

Lytix Biopharma

Market Cap: NOK 615.2m

A clinical stage biotech company, develops novel cancer immunotherapies for cancer therapy in the United States.

LYTIX

NOK 7.76

-4.2%

-14.9%